Medindia LOGIN REGISTER
Medindia

Drug Safety Labeling Changes - February 2012

Food and Drug Administration (FDA) announces important safety label changes for prescription drugs almost every month. By implementing the label changes the FDA warns a physician of new side- effects, adverse reactions, contra-indications and precautions necessary for a drug. This information is important for safe practice of medicine.

Key to Label Sections

  • C - Contraindications
  • W - Warnings
  • P - Precautions
  • AR - Adverse Reactions
Drug Name Sections Modified
C W P AR
Abatacept
Acarbose
Adefovir dipivoxil
Aliskiren and Amlodipine
Aliskiren and hydrochlorothiazide
Aliskiren and valsartan
Aliskiren, Amlodipine and Hydrochlorothiazide
Ambrisentan
Amlodipine, Valsartan and Hydrochlorothiazide
Aripiprazole
Atazanavir
Atorvastatin
Benazepril HCl and Hydrochlorothiazide
Conivaptan
Crizotinib
Darunavir
Dextroamphetamine
Drospirenone and Estradiol
Drospirenone- Estradiol- Levomefolate
Enalapril
Enalapril and Hydrochlorothiazide
Erythromycin
Erythromycin Ethylsuccinate Granules
Estradiol
Estrogen
Ezetimibe and simvastatin
Famciclovir
Fluvastatin
Indinavir
Irbesartan and Hydrochlorothiazide
Lapatinib
Linezolid
Lopinavir and Ritonavir
Lopinavir and Ritonavir
Lovastatin
Nelarabine
Nelfinavir
Niacin Er and Simvastatin
Norfloxacin
Olmesartan
Olopatadine Hydrochloride
Phendimetrazine Tartrate
Pitavastatin
Pravastatin Sodium
Rimexolone ophthalmic
Ritonavir
Rituximab
Rosuvastatin
Saquinavir
Simvastatin
Sitagliptin
Tacrolimus
Theophylline
Tipranavir
Tolvaptan
Valsartan

2016 - Monthly Summary Report for Drug Label Changes

2015 - Monthly Summary Report for Drug Label Changes

2014 - Monthly Summary Report for Drug Label Changes

2013 - Monthly Summary Report for Drug Label Changes

2012 - Monthly Summary Report for Drug Label Changes

Drugs A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Get Health and Wellness Secrets from Our Engaging eBooks
Stay Connected
Available on the Android Market Available on the App Store